I came back to the United States, hearing about a very sad news: Craig Venter passed away today. He is a pioneer, successfully sequenced the first Human genome, and tried to create Synthetic Cells. We lost a giant in Science. RIP. @JCVenterInst

This is truly an exciting and engaging event. The organizers have put a lot of thoughts into this process, to bring out the best experience for every participant! Highly recommend!

🚀The 6th International Directed Evolution Competition will take place in Cambridge! iDEC adopts a milestone-based system, giving more teams a chance to win medals. Visit our website or get in touch: idec.io #iDEC2026 #Cambridge #Bioengineering #AI

NOVA itself is an innovation. As the first decentralized drug screening platform we had a lot of firsts in our nearly first year. From discovering blindspots in SOTA models to building multimillion libraries of novel synthesizable molecules (including ones with a high similarity to patented drugs), we pushed the boundary of AI drug discovery. Our year in review article pinned in our profile goes through more highlights. We’re currently in the process of hit picking molecules for synthesis and wet lab testing. Also, adding a snippet from our conversation today with our partner @Yalotein on the final stages of launching nanobodies. Team is hard at work. More updates coming soon!

Metanova Labs x Yalotein Biotech NOVA next step: nanobodies and decentralized R&D @metanova_labs is pleased to announce the signing of a MOU with Shanghai-based @Yalotein this collaboration will accelerate our roadmap and mark our entry into biological therapeutics. it extends our capabilities beyond virtual small-molecule screening toward a decentralized multi-modal, end-to-end pipeline. strategic inflection point: - unlocking biological modality: we're moving beyond small molecules. nanobodies are a powerful new class of drugs, and this makes them the first biological modality we are adding to NOVA. - closing the loop with wet lab tests: we're solving the critical gap between virtual predictions and real-world validation. @Yalotein will advance 50 nanobody candidates identified by NOVA into in-vitro testing, transforming #Bittensor #SN68 from a predictive tool into the first step of a tangible drug discovery pipeline. Yalotein Biotech focuses on AI-driven development of macromolecular therapeutics. they use advanced AI and data intelligence to accelerate antibody discovery, spanning the entire process from the atomic to the knowledge level. by integrating bioinformatics with AI, they deliver smarter, faster solutions for designing multispecific antibodies and bioconjugates. this partnership is a significant step toward operationalizing our vision of building a truly decentralized pipeline for medical innovation. #drugdiscovery #antibodies #biotech #desci

I'm excited to start the year with @CellChemBiol paper about the machinery that assembles #Geobacter #cytchrome OmcS #nanowires! Led by the super-talented Cong Shen @Aldo_Salazar13 @BuddySphinx @SibelEbruYalcin with @GuptaLab1. @YaleMBB @YaleWestCampus 1/7 dlvr.it/THNSHK

Kicking off Day 1 of the iDEC Festival with an inspiring opening speech by Dr. Zakir Tnimov! 🎉 Followed by nine excellent teams sharing their innovative projects! #iDEC

The iDEC Festival 2024 kicks off on October 26th. We're honored to have iDEC Trustee Dr. Zakir Tnimov delivering the opening speech. Stay tuned for an inspiring start to our event! #iDEC

📢 The iDEC Festival 2024 will take place at the beautiful Homerton College, University of Cambridge! 🌿14 teams will introduce their directed evolution projects—don’t miss it! 🔬@HomertonEvents #iDEC

They should actually teach this in biz school